Starting from December 2019 the novel SARS〤ovhas spread all over the world, being recognized as the causing agent of COVID. Since nowadays no specific drug therapies neither vaccines are available for the treatment of COVID, drug repositioning may offer a strategy to efficiently control the ...
The study aimed to assess the efficacy of transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric (NP) symptoms of the post-acute sequelae of SARS-CoV-2 infection (PASC), known as the long COVID. A double-blind, randomized, sham-controlled study compared the efficac...
Researchers are aggressively studying the emergence of the omicron variant. One of the many questions they're hoping to answer is how well current COVID-19 treatments and therapies will work against omicron. "If you look at the structure ofomicronand compare it to the structure of previous stra...
Current advances in pharmacological treatments for patients with COVID-19 Since the coronavirus disease 2019 (COVID-19) outbreak, more than 150 million people in over 200 countries have been infected, with over 3 million people dying due to it, as of May 1, 2021. Many researchers are working...
Dr David Kaplan discusses the current treatment options for GPP; highlighting the long time to treatment repose, need for combination treatment, and of standard of care guidelines.EP: 1.Overview of Generalized Pustular Psoriasis and Diagnosis Considerations EP: 2.Burden and QoL Impacts on GPP EP:...
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers. January 29th 2025 Niraparib Extends PFS, Time to Next Treatmen...
Due to the high number of cases and the potential for severe disease development, the WHO has listed LASV as a priority pathogen, for which development of efficacious treatments and vaccines is urgently needed [13]. Along these lines, the Coalition for Epidemic Preparedness Innovations (CEPI) ...
Treatment of COVID-19 with TCM So far, no therapeutic agents have been proven to be effective for SARS-CoV-2-caused diseases [36]. TCM is based on the central premise that when pathogens invade the body to cause diseases, they reduce the immune function of the body [37]. In general,...
Since patients with pre-existing pulmonary conditions are at higher risk of COVID-19 and should be closely monitored and cared, pulmonary vasodilator agents have been used in some patients for hypoxemia refractory to conventional treatments, but no study has been performed specifically on COVID-19 ...
Therapies including medicine, specific immunotherapy and cell therapy are expected to play an effective role in treating COVID-19 patients. Here, based on recent research and/or Chinese experi- ence, we comprehensively introduce some effective treatments of patients with COVID-19. Yang et al. ...